Get started
Work

Supplementary Table S1 from Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia

Year: 2025
Type: supplementary-materials
Abstract: Supplementary Table S1. Patient demographics and disease characteristics at baseline by cohort.
DOI: 10.1158/1078-0432.30709227
Authors: John N. Allan, Ian W. Flinn, Tanya Siddiqi, Paolo Ghia, Constantine S. Tam, Thomas J. Kipps, Paul M. Barr, Anna Elinder Camburn, Alessandra Tedeschi, Xavier C. Badoux, Ryan Jacobs, Bryone J. Kuss, Livio Trentin, Cathy Zhou, Anita Szoke, Christopher Abbazio, William G. Wierda
Language: English
Subfield: Genetics
Field: Medicine
Open Access status: gold
OpenAlex ID: W4416630215
Cites:
Cited by:
Related to: 10